Targeting Oxidative Stress With Auranofin or Prima-1(Met) to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells

Ítems similars

• Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells
  per: Benoit Tessoulin, et al.
  Publicat: (2019-03-01)
• Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes
  per: Seiller, Carolane, et al.
  Publicat: (2020)
• Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells
  per: Gillardin, Pierre-Samuel, et al.
  Publicat: (2017)
• Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways
  per: Tessoulin, Benoît, et al.
  Publicat: (2018)
• A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines
  per: Moreaux, Jérôme, et al.
  Publicat: (2011)